# Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

> **NCT00190034** · PHASE4 · SUSPENDED · sponsor: **Far Eastern Memorial Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Cardiovascular Disease
- Renal Insufficiency, Acute
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** N-Acetylcysteine 600mg/tab

## Key facts

- **NCT ID:** NCT00190034
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** opposite result
- **Last updated:** 2009-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190034, "Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00190034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*